# US 2022/0276156 A1 · Methods of characterizing a urine sample

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0276156 A1
- Document ID: US20220276156A1
- Status: Published application
- Kind: A1
- Application number: 17/391,876
- Filed: 2021-08-02
- Published: 2022-09-01
- Earliest claimed: 2016-10-11
- Assignees: Genotox Laboratories
- Applicants: Genotox Laboratories
- Inventors: Nicholas D. Laude; William S. Edgemond; Keqin Gregg
- Web page: https://patentgrep.com/patent/US20220276156A1

## CPC

- G01N 21/3103: {Atomic absorption analysis}
- G01N 21/31: Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry {(G01N21/72 takes precedence)}
- G01N 21/314: {with comparison of measurements at specific and non-specific wavelengths (dual wavelength spectrometry G01J3/427)}
- G01N 21/3151: {using two sources of radiation of different wavelengths (G01N21/33 - G01N21/39 take precedence)}
- G01N 21/6486: {Measuring fluorescence of biological material, e.g. DNA, RNA, cells (G01N21/6428 takes precedence)}
- G01N 21/76: Chemiluminescence; Bioluminescence
- G01N 33/493: urine
- G16H 50/20: for computer-aided diagnosis, e.g. based on medical expert systems
- C12Q 2537/165: Mathematical modelling, e.g. logarithm, ratio
- G01N 21/33: using ultraviolet light (G01N21/39 takes precedence)
- G01N 21/3577: for analysing liquids, e.g. polluted water
- G01N 21/359: using near infrared light
- G01N 21/763: {Bioluminescence}
- G01N 2021/3595: {using FTIR}
- G01N 2201/1293: resolving multicomponent spectra
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

This disclosure relates to methods of characterizing a urine sample from a subject.

## Claims

### Claim at position 1

-50. (canceled)

### Claim 51

A method of characterizing a urine sample from a subject, the method comprising:
(a) providing a urine sample from a subject;
(b) determining one or more of the light absorption, luminescence, phosphorescence, fluorescence, and chemiluminescence of the urine sample at two or more wavelengths of light;
(c) applying one or more eigenvectors derived from a principle component algorithm to a standardized dataset derived from the determined light absorption, luminescence, phosphorescence, fluorescence, and chemiluminescence of the urine sample to generate a Urine Characterization Index (UCI) comprising one or more values for corresponding principle component(s);
(d) characterizing a urine sample as a natural urine sample based on the UCI; and
(e) performing genetic analysis of genetic material present in the urine sample.

### Claim 52 (depends on 51)

The method of claim 51, wherein step (b) comprises determining the light absorption of the urine sample.

### Claim 53 (depends on 52)

The method of claim 52, wherein step (b) comprises determining the light absorption of one or more of ultraviolet light wavelength(s), visible light wavelength(s), near-infrared light wavelength(s), and infrared absorption light wavelengths.

### Claim 54 (depends on 52)

The method of claim 52, wherein step (b) comprises determining the light absorption of the urine sample at wavelengths of about 200 nm to about 1000 nm.

### Claim 55 (depends on 52)

The method of claim 52, wherein step (b) comprises determining the light absorption of the urine sample at wavelengths of about 200 nm to about 340 nm.

### Claim 56 (depends on 52)

The method of claim 52, wherein step (c) comprises applying an eigenvector derived from the principle component algorithm to a dataset derived from the determined light absorption to generate a value for one principle component.

### Claim 57 (depends on 51)

The method of claim 51, wherein step (c) comprises applying two eigenvectors derived from the principle component algorithm to a dataset derived from the determined light absorption, luminescence, phosphorescence, fluorescence, chemiluminescence, or bioluminescence to generate values in two-dimensional principal component space.

### Claim 58 (depends on 57)

The method of claim 57, wherein step (c) comprises applying two eigenvectors derived from the principle component algorithm to a dataset derived from the determined light absorption to generate values in two-dimensional principle component space.

### Claim 59 (depends on 51)

The method of claim 51, wherein step (c) comprising applying three eigenvectors derived from the principle component algorithm to a dataset derived from the determined light absorption, luminescence, phosphorescence, fluorescence, chemiluminescence, or bioluminescence to generate values in three-dimensional principle component space.

### Claim 60 (depends on 59)

The method of claim 59, wherein step (c) comprises applying three eigenvectors derived from the principle component algorithm to a dataset derived from the determined light absorption to generate values in three-dimensional principle component space.

### Claim 61 (depends on 51)

The method of claim 51, wherein step (c) comprising applying four eigenvectors derived from the principle component algorithm to a dataset derived from the determined light absorption, luminescence, phosphorescence, fluorescence, chemiluminescence, or bioluminescence to generate values in four-dimensional principle component space.

### Claim 62 (depends on 61)

The method of claim 61, wherein step (c) comprises applying four eigenvectors derived from the principle component algorithm to a dataset derived from the determined light absorption to generate values in four-dimensional principle component space.

### Claim 63 (depends on 51)

The method of claim 51, wherein step (d) comprises characterizing a urine sample through the use of a clustering algorithm.

### Claim 64 (depends on 63)

The method of claim 63, wherein the clustering algorithm is a hierarchical clustering algorithm, a k-means clustering algorithm, or a statistical distribution model.

### Claim 65 (depends on 51)

The method of claim 51, wherein step (d) comprises characterizing a urine sample by performing regression analysis on the values of principle components.

### Claim 66 (depends on 51)

The method of claim 51, wherein step (d) comprises comparing the UCI of the sample to a UCI of a natural urine sample.

### Claim 67 (depends on 51)

The method of claim 51, wherein steps (b) through (d) are performed before step (e).

### Claim 68 (depends on 51)

The method of claim 51, wherein steps (b) through (d) are performed after step (e).

### Claim 69

A method of characterizing a urine sample from a subject, the method comprising:
(a) providing a urine sample collected from a subject;
(b) determining the absorbance at a first wavelength (A1) and the absorbance at a second wavelength (A2) of the urine sample, wherein the first wavelength is from about 230 nm to 250 nm, and the second wavelength is from about 260 nm to 340 nm;
(c) applying an algorithm to the determined A1 and the determined A2 to generate a Urine Characterization Score (UCS), wherein the algorithm includes a ratio of the determined A1 to the determined A2;
(d) characterizing a urine sample as a natural urine sample based on the UCS; and
(e) performing genetic analysis of genetic material present in the urine sample.

### Claim 70 (depends on 69)

The method of claim 69, wherein the UCS is generated using the Formula (XI):
UCS=A1/A2.

### Claim 71 (depends on 69)

The method of claim 69, wherein the UCS is generated using the Formula (XII):
ti UCS=10×log (A1/A2).

### Claim 72 (depends on 69)

The method of claim 69, wherein the first wavelength is 240 nm and the second wavelength is 280 nm.

### Claim 73 (depends on 70)

The method of claim 70, wherein step (d) comprises charactering the urine sample as a synthetic urine sample if UCS is greater than 0.8.

### Claim 74 (depends on 71)

The method of claim 71, wherein step (d) comprises charactering the urine sample as a synthetic urine sample if the UCS is less than 0.25.

### Claim 75 (depends on 69)

The method of claim 69, wherein steps (b) through (d) are performed before step (e).

### Claim 76 (depends on 69)

The method of claim 69, wherein steps (b) through (d) are performed after step (e).
